Background No specific antiviral drug has been proven effective for treatment of patients
with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside�…

Background An outbreak of coronavirus disease 2019 (COVID-19) occurred in Wuhan,
China; the epidemic is more widespread than initially estimated, with cases now confirmed�…

Artificial intelligence (AI) aims to mimic human cognitive functions. It is bringing a paradigm
shift to healthcare, powered by increasing availability of healthcare data and rapid progress�…

The aim of this study was to analyze the clinical data, discharge rate, and fatality rate of
COVID‐19 patients for clinical help. The clinical data of COVID‐19 patients from December�…

Background: An outbreak of Novel Coronavirus (COVID-19) in Wuhan, China, the epidemic
is more widespread than initially estimated, with cases now confirmed in multiple countries�…

Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel
betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological�…

Abstract 'miR2Disease', a manually curated database, aims at providing a comprehensive
resource of microRNA deregulation in various human diseases. The current version of�…

Background The long-term health consequences of COVID-19 remain largely unclear. The
aim of this study was to describe the long-term health consequences of patients with COVID�…

Background: China bears the biggest stroke burden in the world. However, little is known
about the current prevalence, incidence, and mortality of stroke at the national level, and the�…

Background: Human infections with zoonotic coronaviruses (CoVs), including severe acute
respiratory syndrome (SARS)-CoV and Middle East respiratory syndrome (MERS)-CoV�…